Adam Schlesinger

Advisor at XPHYTO Therapeutics

For over 20 years, Adam has held numerous C-Level transformation and revenue growth leadership roles at multiple banks and technology firms. He is a board advisor to companies in FinTech, BioTech, Consumer Packaged Goods and AI and runs multiple Venture Capital and high yield growth funds. He specializes in revenue growth and M&A transaction advisory.

Adam’s primary experience has been in developing client-focused offerings rooted in technology. He has developed highly innovative front and back-office solutions leveraging modern data and digital tools, processes partnerships and methodologies to push the envelope to challenge the status-quo.

Links

Timeline

  • Advisor

    Current role